Olivier J. Wouters

Policy and Design Considerations for Most-Favored-Nation Drug Pricing

This Viewpoint discusses most-favored-nation drug pricing and how to strengthen this type of drug pricing in Medicare.

Patents on Small-Molecule Drugs Approved by the US Food and Drug Administration, 1990-2019

Importance Patent protection allows pharmaceutical companies to charge high prices for prescription drugs during periods of market exclusivity, and their expiration usually defines when generic competitors can enter the US market. Patents on drug active ingredients are classified...